Clinical Trial Update: ESCAPE Migraine Trial [Phase 3]

View source ↗

Summary

The ESCAPE Migraine Trial, a Phase 3 study sponsored by Abbott Medical Devices, has been terminated; it evaluated a device for migraine disorders and atrial sep…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Septal Defect
• Migraine

Drugs mentioned

• ESCAPE Migraine Trial Device

Snippet

Sponsor: Abbott Medical Devices | Conditions: Migraine Disorders, Heart Septal Defects, Atrial | Phase 3 | Status: TERMINATED